Received Mar 24, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | UNK | Unknown | — |
Patient took the Vivotif vaccine 20 min after eating; Case reference number US-BN-2024-002546 is a spontaneous case initially received from healthcare professional via Med Communications (reference number: USBAV24-2511) on 25-Sep-2024 and concerns a 42-year-old female patient. The patient's medical history and concomitant medication details were not provided. On an unspecified date, as reported the patient ate and after 20 min took a dose of Vivotif (batch number: unknown) at an unknown dose or route of administration, for unknown indication (explicitly coded as 'product administration error'). At the time of the initial report, it was unknown if the patient experienced any adverse events due to Vivotif. Non-significant follow-up was downloaded from VAERS on 09-May-2025 included new reference number. Administrative update performed within the case: Worldwide Unique Case Identification Number (WWID) updated from US-20240925-22332b to US-BAVARIAN NORDIC A/S-US-BN-2024-002546, in accordance with ICH guidance on WWID formatting.; Reporter's Comments: A 42-year-old female patient ate and after 20 min took a dose of Vivotif for unknown indication, which is considered as product administration error. It was unknown if the patient experienced any adverse events due to Vivotif. Product administration error is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Product administration error is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A 42-year-old female patient ate and after 20 min took a dose of Vivotif for unknown indication, which is considered as product administration error. It was unknown if the patient experienced any adverse events due to Vivotif. Product administration error is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Product administration error is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
Comments: None.